The effects of megestrol acetate on nutrition, inflammation and quality of life in elderly haemodialysis patients
- 54 Downloads
Malnutrition, inflammation and poor quality of life are prevalent among elderly haemodialysis patients. Megestrol acetate (MA) is a synthetic progestin that is widely used to increase appetite and weight in various clinical settings. MA has been indicated to be effective in improving quality of life in patients with cancers. The aim of the present study was to evaluate the efficacy and safety of MA in treating malnourished elderly haemodialysis patients.
A randomized controlled study involving 46 hypoalbuminemia haemodialysis patients aged 70 years or older was conducted. The patients in MA-treated group (n = 23) took 160 mg of MA daily, while those in control group (n = 23) were enrolled without any intervention. Anthropometric parameters and laboratory results, including height, dry weight, body mass index, and modified subjective global assessment score as well as serum albumin, triglyceride, total cholesterol, hsCRP, IL-1b and IL-6 concentrations were measured in all patients before and after the intervention. Health-related quality of life was also evaluated using the KDQOL-SF 1.3.
In the MA-treated group, a total of 18 patients finished the therapy over a 3-month period. Appetite was reported as improved by 15 patients, and a statistically significant increase was observed in dry weight (53.36 ± 6.15 vs. 54.24 ± 6.32, P < 0.01) and serum albumin concentration (29.05 ± 3.91 vs. 37.67 ± 4.88, P < 0.01) in the MA-treated group compared to those of the control group. The quality of life in both the physical domain (46.73 ± 18.17 vs. 63.37 ± 22.35, P < 0.01) and the mental domain (50.28 ± 20.36 vs. 68.02 ± 25.48, P < 0.01) was also improved in the same group. There was no significant change in the inflammatory marker concentrations after the intervention. No serious or unexpected adverse events were observed except that one patient who withdrew due to excessive fluid gain between haemodialysis sessions.
Our data suggest that MA can be effective in improving nutritional status and quality of life by increasing appetite in elderly haemodialysis patients with acceptable side effects; however, MA might not ameliorate inflammation.
KeywordsMegestrol acetate Haemodialysis Malnutrition Quality of life
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 2.Stevens LA, Viswanathan G, Weiner DE (2010) Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis 17(4):293–301. https://doi.org/10.1053/j.ackd.2010.03.010 CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Heng AE, Cano NJM (2010) Nutritional problems in adult patients with stage 5 chronic kidney disease on dialysis (both haemodialysis and peritoneal dialysis). NDT Plus 3(2):109–117Google Scholar
- 10.Seckinger J, Dschietzig W, Leimenstoll G, Rob PM, Kuhlmann MK, Pommer W, Fraass U, Ritz E, Schwenger V (2016) Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study. Clin Kidney J 9(6):839–848. https://doi.org/10.1093/ckj/sfw087 CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Golebiewska JE, Lichodziejewska-Niemierko M, Aleksandrowicz-Wrona E, Majkowicz M, Lysiak-Szydlowska W, Rutkowski B (2012) Influence of megestrol acetate on nutrition, inflammation and quality of life in dialysis patients. Int Urol Nephrol 44(4):1211–1222. https://doi.org/10.1007/s11255-011-0025-8 CrossRefPubMedGoogle Scholar
- 16.Fernandez Lucas M, Teruel JL, Burguera V, Sosa H, Rivera M, Rodriguez Palomares JR, Marcen R, Quereda C (2010) Treatment of uraemic anorexia with megestrol acetate. Nefrologia: publicacion oficial de la Sociedad Espanola Nefrologia 30(6):646–652. https://doi.org/10.3265/Nefrologia.pre2010.Aug.10546 CrossRefGoogle Scholar
- 18.Lopes AA, Elder SJ, Ginsberg N, Andreucci VE, Cruz JM, Fukuhara S, Mapes DL, Saito A, Pisoni RL, Saran R, Port FK (2007) Lack of appetite in haemodialysis patients–associations with patient characteristics, indicators of nutritional status and outcomes in the international DOPPS. Nephrol Dial Transplant 22(12):3538–3546. https://doi.org/10.1093/ndt/gfm453 CrossRefPubMedGoogle Scholar
- 19.Hays RD AN, Alonso J, et al (1997) Kidney disease quality of life short form (KDQOLSF), version 1.3: a manual for use and scoring. http://www.randorg/pubs/papers/2006/P7994pdf. Accessed 21 Oct 2011
- 20.Yamashita M, Komatsu R, Maruyama Y, Takaki T, Ichinose H, Sasaki O, Sawase K, Harada T, Funakoshi S (2018) Dietary approach to improving the nutritional status in institutionalized elderly hemodialysis patients with a poor dietary intake: a single-arm pilot study. Nihon Ronen Igakkai zasshi Jpn J Geriatr 55(1):90–97. https://doi.org/10.3143/geriatrics.55.90 CrossRefGoogle Scholar
- 27.Mikolasevic I, Lukenda V, Racki S, Milic S, Sladoje-Martinovic B, Orlic L (2014) Nonalcoholic fatty liver disease (NAFLD)-a new factor that interplays between inflammation, malnutrition, and atherosclerosis in elderly hemodialysis patients. Clin Interv Aging 9:1295–1303. https://doi.org/10.2147/cia.s65382 CrossRefPubMedPubMedCentralGoogle Scholar